Zobrazeno 1 - 10
of 78
pro vyhledávání: '"A E, Fusaro"'
Publikováno v:
Reumatismo, Vol 65, Iss 6, Pp 286-291 (2014)
The objective of this study was to evaluate the efficacy of the endothelin receptor antagonist, bosentan, in patients with Raynaud’s phenomenon secondary to systemic sclerosis never treated with prostanoids and without digital ulcers. The study des
Externí odkaz:
https://doaj.org/article/19ee1325f6c94695a984b80106d3b49a
Autor:
S. Parisi, A. Becciolini, M. C. Ditto, A. Ariani, A. Ianniello, M. Priora, M. Paroli, C. Realmuto, C. L. Peroni, C. M. Centanaro Di Vittorio, R. Degiovanni, A. Laganà, E. Fusaro
Publikováno v:
Annals of the Rheumatic Diseases. 81:1295-1296
BackgroundAntiTNF-α biosimilars are broadly available for the treatment of inflammatory arthritis. There are a lot of data concerning the maintenance of clinical efficacy after switching from originators to biosimilars. However, there is lack of dat
Autor:
A. Ariani, S. Parisi, P. Del Medico, A. Farina, E. Visalli, A. Molica Colella, F. Lumetti, R. Caccavale, P. Scolieri, R. Andracco, F. Girelli, E. Bravi, M. Colina, V. Franchina, I. Platé, E. DI Donato, G. Amato, C. Salvarani, F. De Lucia, D. Santilli, E. Arrigoni, F. Mozzani, R. Foti, G. Sandri, V. Bruzzese, M. Paroli, E. Fusaro, A. Becciolini
Publikováno v:
Annals of the Rheumatic Diseases. 81:825-826
BackgroundApremilast, an inhibitor of the phosphodiesterase 4, is indicated for Psoriatic Arthritis (PsA) treatment. The 3 years retention rate, an outcome indirectly related to efficacy, observed in clinical trials [1] is 55,5%. A single subsequent
Autor:
M. Fornaro, F. Franceschini, E. Gremese, A. Cauli, M. Sebastiani, C. Montecucco, F. Conti, M. Rossini, R. Foti, F. P. Cantatore, E. Fusaro, C. Lomater, B. Frediani, M. Govoni, F. Atzeni, R. Ramonda, S. D’angelo, G. Ferraccioli, G. Lapadula, R. Caporali, F. Iannone
Publikováno v:
Annals of the Rheumatic Diseases. 81:585-586
BackgroundIn real-life setting, a greater number of elderly rheumatoid arthritis (RA) patients with impaired glomerular filtration rate (GFR) needs treatment with biologic or target synthetic disease-modifying anti-rheumatic drugs (b/tsDMARD) to achi
Autor:
C. Ferri, V. Raimondo, L. Gragnani, D. Giuggioli, L. Dagna, A. Tavoni, F. Ursini, M. L’andolina, F. Caso, P. Ruscitti, M. Caminiti, R. Foti, V. Riccieri, S. Guiducci, R. Pellegrini, E. Zanatta, G. Varcasia, D. Olivo, P. Gigliotti, G. Cuomo, G. Murdaca, R. Cecchetti, R. De Angelis, N. Romeo, F. Ingegnoli, F. Cozzi, V. Codullo, I. Cavazzana, M. Colaci, G. Abignano, M. De Santis, E. Lubrano, E. Fusaro, A. Spinella, F. Lumetti, G. De Luca, S. Bellando Randone, E. Visalli, Y. Dal Bosco, G. Amato, D. Giannini, S. Bilia, F. Masini, G. Pellegrino, E. Pigatto, E. Generali, G. Pagano Mariano, G. Pettiti, G. Zanframundo, R. Brittelli, V. Aiello, R. Caminiti, D. Scorpiniti, T. Ferrari, C. Campochiaro, V. Brusi, M. Fredi, L. Moschetti, F. Cacciapaglia, S. M. Ferrari, I. DI Cola, M. Vadacca, S. Lorusso, M. Monti, S. Lorini, S. R. Paparo, F. Ragusa, G. Elia, V. Mazzi, M. L. Aprile, M. Tasso, M. Miccoli, S. L. Bosello, S. D’angelo, A. Doria, F. Franceschini, R. Meliconi, M. Matucci-Cerinic, F. Iannone, R. Giacomelli, C. Salvarani, A. L. Zignego, P. Fallahi, A. Antonelli
Publikováno v:
Annals of the Rheumatic Diseases. 81:970.2-971
BackgroundPatients with autoimmune systemic diseases (ASDs) can be counted among frail populations as regards the predisposition to COVID-19 due to the frequent visceral organ involvement and comorbidities, as well as the ongoing immunomodulating tre
Autor:
Valentina Gasco, M. C. Ditto, Chiara Bona, Alessandro Maria Berton, Nunzia Prencipe, Silvia Grottoli, S. Parisi, M. Scarati, T. Manetta, E. Fusaro, Mirko Parasiliti-Caprino
Publikováno v:
Journal of endocrinological investigation. 43(11)
The aim of the present study was to evaluate the rheumatic profile in acromegalic patients to better characterize joint pain. The immunological pattern (rheumatoid factor; antinuclear antibodies—ANA, extractable nuclear antigens—ENA-Ab; anti-citr
Autor:
Raffaella Landi, Eleonora Rizzi, C Realmuto, M Parodi, Mattia Bellan, A Finucci, P Rossi, Giuseppe Francesco Casciaro, Filippo Patrucco, P.P. Sainaghi, Mario Pirisi, Anita R. Pedrinelli, Micol Giulia Cittone, M C Ditto, Cristina Rigamonti, M Todoerti, Veronica Vassia, P Stobbione, S Parisi, E Fusaro
Publikováno v:
Scandinavian Journal of Rheumatology
The outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, causing coronavirus disease 2019 (COVID-19), has had a deleterious effect on the delivery of care for all acu...
IMPORTANCE Meropenem-vaborbactam is a combination carbapenem/beta-lactamase inhibitor and a potential treatment for severe drug-resistant gram-negative infections. OBJECTIVE To evaluate efficacy and adverse events of meropenem-vaborbactam in complica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::4b9cdb2669ed3c66b1d1469f40bdfcff
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3107675
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3107675
Autor:
S, Parisi, C, Celletti, M, Scarati, M, Priora, A, Laganà, C L, Peroni, F, Camerota, G, La Torre, D, Blow, E, Fusaro
Publikováno v:
La Clinica terapeutica. 168(6)
Hand functioning is often impaired in patients with Systemic sclerosis. Neuromuscular Taping is a novel application of tape able to improve functioning. The aim of this study was to evaluate the possible role of this application in the hand functiona
Publikováno v:
Poster Presentations.
Background Transition is a multifaceted process involving medical, psychosocial, educational needs of the teenager who must move from a pediatric care to adult care system. The pediatric paradigm focuses on the family, it focuses on aspects of growth